Maque, Baby Girl .

HRN: 28-84-22  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2026
AMPICILLIN 250MG (VIAL)
04/16/2026
04/22/2026
IVT
140mg
Q12H
NAMF (PROM X 45 Hours)
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: